45 results
424B3
ADAP
Adaptimmune Therapeutics Plc
20 Apr 23
Prospectus supplement
4:32pm
to confidentiality, non-disclosure or privacy;
materially interfere with the conduct of the party’s business; or
of the party’s board of directors or its
S-4/A
ADAP
Adaptimmune Therapeutics Plc
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
to confidentiality, non-disclosure or privacy;
materially interfere with the conduct of the party’s business; or
of the party’s board of directors or its
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
with any Third Party (including informed consents or privacy consents) or otherwise violating any Applicable Law. “Control” or “Controls” shall … (CTAs).
(mm)
“Data Protection Law” means any and all Applicable Laws relating to privacy and data protection, direct marketing or the interception
S-4
ADAP
Adaptimmune Therapeutics Plc
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
) to be undermined with respect to the information;
violating any obligation with respect to confidentiality, non-disclosure or privacy;
materially
S-3ASR
EX-1.2
3on qvd029zk
10 Aug 20
Automatic shelf registration
5:01pm
8-K
EX-1.1
9uf1g3fs
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
8-K
EX-1.1
8ij7 9ot13tw
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm
8-K
EX-10.1
k0fdm
27 Aug 19
Entry into a Material Definitive Agreement
8:39am